Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Reinhard Reuss"'
Autor:
Reinhard Reuss, Jörg Kraus, Peter Wipfler, Peter Young, Franz Blaes, Rainer Dziewas, Patrick Oschmann, Alexander Kunz
Publikováno v:
Cerebrovascular Diseases. 33:453-460
Objective: Although sleep apnea (SA) is a risk factor for ischemic stroke and an important prognostic factor in affected patients, the exact pathophysiological link between SA and stroke is unknown. We investigated whether the plasma concentration of
Autor:
Reinhard Reuss, Marta Mistarz, Andreas Mirau, Jörg Kraus, Rolf-Hasso Bödeker, Patrick Oschmann
Publikováno v:
Neuroimmunomodulation. 21(5)
Objective: To elucidate the role of tumor necrosis factor (TNF) receptor signal transduction in multiple sclerosis (MS). Methods: We performed a cross-sectional analysis of the gene expression of TNF receptor-associated death domain protein (TRADD) a
Autor:
Rolf-Hasso Bödeker, Jörg Kraus, Reinhard Reuß, Marta Mistarz, Andreas Mirau, Patrick Oschmann
Publikováno v:
Neuroimmunomodulation. 20(3)
Objective: To elucidate the role of tumor necrosis factor (TNF) receptor signal transduction in multiple sclerosis (MS). Methods: We performed a cross-sectional analysis of the gene expression of TRAF2 (TNF receptor-associated factor 2) and RIP (rece
Autor:
Martin Marziniak, Christoph Kleinschnitz, Ulf Ziemann, Johannes Brettschneider, Peter Kern, Christian Veauthier, Hans Hartung, Alexander Winkelmann, Hannah L. Pellkofer, Florian Then Bergh, Martin Liebetrau, Orhan Aktas, C. Wilke, Sven Schippling, Kersten Guthke, Stefan Langel, Christoph Mayer, Martin Stangel, Reinhard Reuss, Uwe K Zettl U, Ingo Kleiter, Paulus S. Rommer, Jörn P Sieb, Florian Lauda, Achim Berthele, Jürgen H. Faiss, Corinna Trebst, Christian Geis, Christoph Münch, Sabine Niehaus, Kerstin Hellwig, Ralf A. Linker, Tobias Boettcher, Marius Ringelstein, Christian Zentner, Sven Jarius, Klaus Peter Wandinger, Arthur Melms, Klemens Ruprecht, Brigitte Wildemann, Frank Hoffmann, Hayrettin Tumani, Friedemann Paul, Imke Metz, Tania Kuempfel, Barbara Ettrich, Ulrich Hofstadt-van Oy, Bernhard Hemmer, Oliver Neuhaus
Publikováno v:
Journal of Neuroinflammation, 9. BioMed Central Ltd
Journal of Neuroinflammation, Vol 9, Iss 1, p 14 (2012)
Journal of Neuroinflammation
Journal of Neuroinflammation, Vol 9, Iss 1, p 14 (2012)
Journal of Neuroinflammation
Background The diagnostic and pathophysiological relevance of antibodies to aquaporin-4 (AQP4-Ab) in patients with neuromyelitis optica spectrum disorders (NMOSD) has been intensively studied. However, little is known so far about the clinical impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56aac65db922f51bce17d372940b76e3
http://publikationen.ub.uni-frankfurt.de/files/26774/1742-2094-9-14.pdf
http://publikationen.ub.uni-frankfurt.de/files/26774/1742-2094-9-14.pdf
Autor:
Ingo Kleiter, Klemens Ruprecht, Marius Ringelstein, Wolfgang Kristoferitsch, Oliver Stich, Diego Franciotta, Klaus-Peter Wandinger, Sebastian Rauer, Sven Jarius, Brigitte Wildemann, Paulus S. Rommer, Friedemann Paul, Arthur Melms, Reinhard Reuss, Roberto Bergamaschi, Uwe K. Zettl, Orhan Aktas
Publikováno v:
Journal of the neurological sciences. 306(1-2)
Background Neuromyelitis optica (NMO, Devic disease) is a severely disabling autoimmune disorder of the CNS, which was considered a subtype of multiple sclerosis (MS) for many decades. Recently, however, highly specific serum autoantibodies (termed N
Autor:
Klaus-Peter Wandinger, Brigitte Wildemann, Friedemann Paul, Roberto Bergamaschi, Paulus S. Rommer, Reinhard Reuss, Sven Jarius, Christian Probst, Klemens Ruprecht, Wolfgang Kristoferitsch, Diego Franciotta
Publikováno v:
Journal of Neuroinflammation 7: 52.
Journal of Neuroinflammation, Vol 7, Iss 1, p 52 (2010)
Journal of Neuroinflammation
Journal of Neuroinflammation, Vol 7, Iss 1, p 52 (2010)
Journal of Neuroinflammation
Background In 70-80% of cases, neuromyelitis optica (NMO) is associated with highly specific serum auto-antibodies to aquaporin-4 (termed AQP4-Ab or NMO-IgG). Recent evidence strongly suggests that AQP4-Ab are directly involved in the immunopathogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b84eb789d1890b04ecf9419783ec786
http://edoc.mdc-berlin.de/11358/
http://edoc.mdc-berlin.de/11358/
Autor:
Sven Jarius, Michael Bolz, Annette Grossmann, Paulus S. Rommer, Tobias Boettcher, Uwe K. Zettl, Alexander Bock, Wolfgang Brück, Reinhard Reuss, Reiner Benecke, Frauke Zipp, Friedemann Paul
Publikováno v:
Scopus-Elsevier
Four weeks ago ( BMJ 2009;339:b3862) we described the case of 23 year old Andrea G, who presented with progressive transverse spinal cord syndrome in early pregnancy. Her symptoms recurred during a subsequent pregnancy ( BMJ 2009;339:b4025). We consi
Autor:
Michael Bolz, Frauke Zipp, Wolfgang Brück, Reinhard Reuss, Paulus S. Rommer, Friedemann Paul, Alexander Bock, Uwe K. Zettl, Sven Jarius, Reiner Benecke, Annette Grossmann, Tobias Boettcher
In March 2006, Andrea G, a 23 year old white nulliparous woman who was 17 weeks pregnant, was referred to her local neurology department. She had been experiencing hypoaesthesia of the right leg for seven days and of the left leg for two days. Since
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::899a2e74e357df4a226396766d186050
http://edoc.mdc-berlin.de/10573/1/10573oa.pdf
http://edoc.mdc-berlin.de/10573/1/10573oa.pdf
Publikováno v:
Pharmacology. 84(2)
The muscle-relaxing 5-HT2 receptor antagonist cyclobenzaprine is structurally closely related to amitriptyline. It is widely used to treat patients presenting with back pain and fibromyalgia. Very rarely cyclobenzaprine toxicity can result in extrapy
Autor:
Winfried Padberg, Martina Sauter, Susanne Aberle, Karin Klingel, Nikolaus Blin, Folker Ernst Franke, Annette Greschniok, Reinhard Reuss
Publikováno v:
International journal of oncology. 29(3)
Since pancreatic cancer is an aggressive and often incurable malignancy, we investigated if the carboxyl ester lipase gene (CEL) is specifically expressed in pancreatic tissues and its promoter can be used for a specific suicide gene approach. Twenty